Document is current
Any future updates will be listed below
-
Authors
Müller, Fabian https://orcid.org/0000-0001-5487-5839
Hagen, Melanie
Wirsching, Andreas
Kharboutli, Soraya
Aigner, Michael
Völkl, Simon https://orcid.org/0000-0003-2193-3048
Kretschmann, Sascha https://orcid.org/0000-0001-8168-7542
Tascilar, Koray https://orcid.org/0000-0002-8109-826X
Taubmann, Jule
Bucci, Laura
Raimondo, Maria Gabriella https://orcid.org/0000-0003-2020-6711
Bergmann, Christina https://orcid.org/0000-0001-5257-9171
Rothe, Tobias
Corte, Giulia
Tur, Carlo https://orcid.org/0009-0003-6241-6116
Muñoz, Luis https://orcid.org/0000-0002-5395-804X
Böltz, Sebastian https://orcid.org/0000-0001-5227-8707
Schuster, Louis
Hartmann, Fabian https://orcid.org/0000-0001-6106-1657
Garantziotis, Panagiotis
Spörl, Silvia
Vasova, Ingrid
Gerbitz, Armin
Spriewald, Bernd
Kiener, Hans
Giannarelli, Diana
Locatelli, Franco https://orcid.org/0000-0002-7976-3654
D’Agostino, Maria-Antonietta
Hanssens, Linda
Miltenyi, Stefan
Bozec, Aline
Grieshaber-Bouyer, Ricardo https://orcid.org/0000-0002-2873-5135
Mackensen, Andreas https://orcid.org/0000-0002-0685-4483
Schett, Georg https://orcid.org/0000-0001-8740-9615
- License Information
-
More Information
Article History
Received: 30 September 2025
Accepted: 15 December 2025
First Online: 7 January 2026
Competing interests
: A.W., S.K., M.A., S.V., S.K., K.T., J.T., L.B., M.G.R., C.B., T.R., C.T., L.M., S.B., L.S., F.H., P.G., S.S., I.V., A.G., B.S., H.K., D.G., F.L. and A.B. declare no conflicts of interest. F.M. has received research support from AstraZeneca, Bristol Myers Squibb, Kite/Gilead and Miltenyi Bioscience; has consulted for AstraZeneca, ArgoBio, Bristol Myers Squibb, CRISPR Therapeutics, EcoR1, Incyte, Janssen, Kite/Gilead, Miltenyi Bioscience, Novartis and Sobi; and has received speaker’s honoraria from AbbVie, AstraZeneca, BeiGene, Bristol Myers Squibb, Incyte, Janssen, Kite/Gilead, Miltenyi Bioscience, Merck Sharp & Dohme, Novartis, Pfizer, Sobi and Takeda. M.H. has received speaker’s honoraria from Bristol Myers Squibb, AstraZeneca, Century and Lilly, which are not related to this study. S.V. has received research support from Bristol Myers Squibb. A.M. has received speaker’s honoraria from Bristol Myers Squibb, Celgene, Gilead, Janssen, Kite, Miltenyi Biomedicine and Novartis, which were not related to this study. G.S. has received speaker’s honoraria from Bristol Myers Squibb, Cabaletta, Janssen, Kyverna, Novartis and UCB, which were not related to this study. M.-A.D. has received speaker’s honoraria from AbbVie, Bristol Myers Squibb, Lilly, Janssen, Novartis and UCB. L.H. is an employee of Miltenyi Biotec. S.M. is the founder of Miltenyi Biotec. R.G.-B. is co-founder of Epana Bio.
